Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis

N Bobrovitz, RK Arora, C Cao, E Boucher, M Liu… - PloS one, 2021 - journals.plos.org
Background Many studies report the seroprevalence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies. We aimed to synthesize seroprevalence data to …

Reconciling estimates of global spread and infection fatality rates of COVID‐19: an overview of systematic evaluations

JPA Ioannidis - European journal of clinical investigation, 2021 - Wiley Online Library
Background Estimates of community spread and infection fatality rate (IFR) of COVID‐19
have varied across studies. Efforts to synthesize the evidence reach seemingly discrepant …

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

CH Hansen, D Michlmayr, SM Gubbels, K Mølbak… - The lancet, 2021 - thelancet.com
Background The degree to which infection with SARS-CoV-2 confers protection towards
subsequent reinfection is not well described. In 2020, as part of Denmark's extensive, free-of …

How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic

S Singh, C McNab, RMK Olson, N Bristol, C Nolan… - The Lancet, 2021 - thelancet.com
Understanding the spread of SARS-CoV-2, how and when evidence emerged, and the
timing of local, national, regional, and global responses is essential to establish how an …

Current and innovative methods for the diagnosis of COVID‑19 infection

L Falzone, G Gattuso, A Tsatsakis… - International …, 2021 - spandidos-publications.com
Abstract The Coronavirus Disease 2019 (COVID‑19) pandemic has forced the scientific
community to rapidly develop highly reliable diagnostic methods in order to effectively and …

Immunity to SARS‐CoV‐2 induced by infection or vaccination

X Castro Dopico, S Ols, K Loré… - Journal of internal …, 2022 - Wiley Online Library
Adaptive immune responses play critical roles in viral clearance and protection against re‐
infection, and SARS‐CoV‐2 is no exception. What is exceptional is the rapid …

SARS‐CoV‐2 re‐infection risk in Austria

S Pilz, A Chakeri, JPA Ioannidis… - European journal of …, 2021 - Wiley Online Library
Background A key question concerning coronavirus disease 2019 (COVID‐19) is how
effective and long lasting immunity against this disease is in individuals who were previously …

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

H Kalish, C Klumpp-Thomas, S Hunsberger… - Science translational …, 2021 - science.org
Asymptomatic SARS-CoV-2 infection and delayed implementation of diagnostics have led to
poorly defined viral prevalence rates in the United States and elsewhere. To address this …

A look into the future of the COVID-19 pandemic in Europe: an expert consultation

EN Iftekhar, V Priesemann, R Balling… - The Lancet Regional …, 2021 - thelancet.com
How will the coronavirus disease 2019 (COVID-19) pandemic develop in the coming months
and years? Based on an expert survey, we examine key aspects that are likely to influence …

Controlling the pandemic during the SARS-CoV-2 vaccination rollout

J Viana, CH van Dorp, A Nunes, MC Gomes… - Nature …, 2021 - nature.com
There is a consensus that mass vaccination against SARS-CoV-2 will ultimately end the
COVID-19 pandemic. However, it is not clear when and which control measures can be …